Research Idea
Research content for general circulation. Not individualized advice.Ā Methodology & Disclosures
Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Price Behavior
Key Price Behavior Insights: ā¢ Breakout reversal ā¢ Oversold bounce ā¢ Support test Support Level: $74-$75 Resistance Level: $84-$90 HNGE has reversed sharply from its early-July breakout, now trading below its last month average with oversold RSI that could spark a bounce, but a break below $74 would keep downside risk elevated.
Sentiment & News
Key News Insights: ā¢ Rally fatigue ā¢ Insider selling ā¢ Q2 catalyst Hinge Health's sharp rally has drawn bullish coverage, but a downgrade and insider selling point to rising caution ahead of its Aug. 4 Q2 earnings update.
AI Summary
Hinge Health is now a āprove-itā stock: Q1's 47% growth and improving cash-flow profile support the bull case, but after the sharp run-up and failed breakout, the current ~10x sales valuation leaves little room for any slowdown, so the August earnings report must confirm sustained growth, margin expansion, and positive free cash flow or the stock likely de-rates.
Description
Hinge Health develops software for musculoskeletal care, providing digital programs and services that support treatment of acute injuries, chronic pain and post-operative rehabilitation. The company also offers administrative and operational support to health plans and employers. Founded in 2012, it is headquartered in San Francisco, California.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Jun 17 | Jun 24 | HNGE | Hinge Health, Inc. | Positive catalyst-plus-momentum setup: Q1 revenue grew 47% YoY to $182.3M, net income turned positive at $35.1M, free cash flow was $41.6M, and management raised full-year guidance. Product expansion, 24 state employee health plan clients, and strong ROI data support near-term sentiment. | Closed | +5.3% |
| May 14 | May 21 | HNGE | Hinge Health, Inc. | Healthcare momentum candidate with strong execution: Q1 revenue was $182M, up 47% YoY and ahead of expectations, margins improved, management raised full-year revenue guidance, and Q1 free cash flow was $41.6M. Stock is up about 25% over the last 21 trading days with only a modest pullback from its recent high. | Closed | +2.3% |